Ayrshire Capital Management LLC

Position in JNJ — Johnson & Johnson

CIK 1801563 WESTPORT, CT

Position in JNJ

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$205,207

-$4,497,933 QoQ

Shares Held

808

-97.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#4,477

of 4,664 holders

Holding Since

Mar 2020

17 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ayrshire Capital Management LLC holds $9,068,388 across 4 Drug Manufacturers - General names. JNJ ranks #4 (2.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	6,630	$7,952,221
2	GILD	Gilead Sciences, Inc.	5,462	$690,069
3	MRK	Merck & Co., Inc.	1,719	$220,891
4	JNJ	Johnson & Johnson This page	808	$205,207

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$205,207	808	-97.3%	Shares	Sole	2026-07-14
2023-12-31	$4,703,140	30,006	+1.9%	Shares	Sole	2024-01-09
2023-09-30	$4,584,657	29,436	+0.5%	Shares	Sole	2023-10-12
2023-06-30	$4,846,260	29,279	+0.9%	Shares	Sole	2023-07-14
2023-03-31	$4,498,720	29,024	-8.9%	Shares	Sole	2023-04-13
2022-12-31	$5,625,242	31,844	-8.7%	Shares	Sole	2023-01-11
2022-09-30	$5,694,729	34,860	+3.3%	Shares	Sole	2022-10-11
2022-06-30	$5,989,187	33,740	-3.1%	Shares	Sole	2022-07-08
2022-03-31	$6,168,490	34,805	+0.6%	Shares	Sole	2022-04-19
2021-12-31	$5,919,022	34,600	+3.7%	Shares	Sole	2022-01-12
2021-09-30	$5,390,547	33,378	+3.7%	Shares	Sole	2021-10-12
2021-06-30	$5,301,168	32,179	-2.5%	Shares	Sole	2021-08-10
2021-03-31	$5,421,577	32,988	+3.5%	Shares	Sole	2021-05-11
2020-12-31	$5,017,274	31,880	+5.3%	Shares	Sole	2021-01-21
2020-09-30	$4,508,681	30,284	+8.8%	Shares	Sole	2020-10-20
2020-06-30	$3,915,982	27,846	+8.7%	Shares	Sole	2020-08-14
2020-03-31	$3,357,977	25,608	—	Shares	Sole	2020-04-17
No filing history on record for this holder in this stock.